Robert Dickey

EXECUTIVE BIO

Robert Dickey IV

Senior life sciences finance executive, board director, and strategic advisor with three decades of leadership across biotechnology, medical devices, and global capital markets.

Schedule a Confidential Conversation

Dead trees stand on cracked desert floor with orange dune.

(1985–1996)

Lehman Brothers

a person reading a newspaper next to a laptop computer

(1996–2018)

Public Company CFO Roles

team members gripping wrists in unity gesture

(2018–Present)

Board & Governance Leadership

Board director at AngioGenex, SFA Therapeutics, and GSNO Therapeutics.

(2020–Present)

Foresite Advisors

(1985–1996)

Lehman Brothers

Co-founded the Middle Market Group; executed $1B+ in aggregate M&A and capital markets transactions.

(1996–2018)

Public Company CFO Roles

Led IPO preparation, reverse mergers, and capital raises at Protarga, Hemispherx Biopharma, NeoStem, and Motif Bio.

(2018–Present)

Board & Governance Leadership

Board director at AngioGenex, SFA Therapeutics, and GSNO Therapeutics.

a tall building with a sign on the side of it

(2020–Present)

Foresite Advisors

Founder & Managing Director; fractional CFO and transaction advisor to 19+ life sciences companies.

(1985–1996)

Lehman Brothers

Co-founded the Middle Market Group; executed $1B+ in aggregate M&A and capital markets transactions.

(1996–2018)

Public Company CFO Roles

Led IPO preparation, reverse mergers, and capital raises at Protarga, Hemispherx Biopharma, NeoStem, and Motif Bio.

(2018–Present)

Board & Governance Leadership

Board director at AngioGenex, SFA Therapeutics, and GSNO Therapeutics.

(2020–Present)

Foresite Advisors

Founder & Managing Director; fractional CFO and transaction advisor to 19+ life sciences companies.

Career Timeline

Career Path

Three decades of leadership across investment banking, public-company executive roles, and board governance — building toward a fractional advisory practice serving the life sciences industry today.

My services

What I do

Capital Formation Strategy

Fractional CFO and transaction advisor; public listing readiness, reverse mergers, SPACs, venture debt, and M&A.

Modern glass skyscraper against a clear blue sky.

1

a group of red cubes on a gray background

2

3

Capital Formation Strategy

Fractional CFO and transaction advisor; public listing readiness, reverse mergers, SPACs, venture debt, and M&A.

Board & Governance Advisory

Audit committee leadership, SEC compliance oversight, shareholder alignment.

Strategic Exits & Restructuring

Chapter 11 reorganizations, strategic alternatives, M&A execution.

My services

Education

MBA in Finance

The Wharton School, University of Pennsylvania.

AB (Bachelor of Arts), Economics

Princeton University.

Managing Director at Foresite Advisors — he helps life sciences companies raise capital, navigate deals, and stay on solid financial footing — as a hands-on CFO advisor and as a board director.

Home

Executive Bio

Board

Advisory

Track Record

Contact

CONTACT

Philadelphia

Managing Director at Foresite Advisors — he helps life sciences companies raise capital, navigate deals, and stay on solid financial footing — as a hands-on CFO advisor and as a board director.

Home

Executive Bio

Board

Advisory

Track Record

Contact

CONTACT

Philadelphia

Managing Director at Foresite Advisors — he helps life sciences companies raise capital, navigate deals, and stay on solid financial footing — as a hands-on CFO advisor and as a board director.

Home

Executive Bio

Board

Advisory

Track Record

Contact

CONTACT

Philadelphia